Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease - PubMed (original) (raw)
Meta-Analysis
Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease
Lynne V McFarland. Am J Gastroenterol. 2006 Apr.
Abstract
Context: Antibiotic-associated diarrhea (AAD) is a common complication of most antibiotics and Clostridium difficile disease (CDD), which also is incited by antibiotics, is a leading cause of nosocomial outbreaks of diarrhea and colitis. The use of probiotics for these two related diseases remains controversial.
Objective: To compare the efficacy of probiotics for the prevention of AAD and the treatment of CDD based on the published randomized, controlled clinical trials.
Data sources: PubMed, Medline, Google Scholar, NIH registry of clinical trials, metaRegister, and Cochrane Central Register of Controlled Trials were searched from 1977 to 2005, unrestricted by language. Secondary searches of reference lists, authors, reviews, commentaries, associated diseases, books, and meeting abstracts.
Study selection: Trials were included in which specific probiotics given to either prevent or treat the diseases of interest. Trials were required to be randomized, controlled, blinded efficacy trials in humans published in peer-reviewed journals. Trials that were excluded were pre-clinical, safety, Phase 1 studies in volunteers, reviews, duplicate reports, trials of unspecified probiotics, trials of prebiotics, not the disease being studied, or inconsistent outcome measures. Thirty-one of 180 screened studies (totally 3,164 subjects) met the inclusion and exclusion criteria.
Data extraction: One reviewer identified studies and abstracted data on sample size, population characteristics, treatments, and outcomes.
Data synthesis: From 25 randomized controlled trials (RCTs), probiotics significantly reduced the relative risk of AAD (RR = 0.43, 95% CI 0.31, 0.58, p < 0.001). From six randomized trials, probiotics had significant efficacy for CDD (RR = 0.59, 95% CI 0.41, 0.85, p = 0.005).
Conclusion: A variety of different types of probiotics show promise as effective therapies for these two diseases. Using meta-analyses, three types of probiotics (Saccharomyces boulardii, Lactobacillus rhamnosus GG, and probiotic mixtures) significantly reduced the development of antibiotic-associated diarrhea. Only S. boulardii was effective for CDD.
Comment in
- Inappropriate use of meta-analysis to estimate efficacy of probiotics.
Dendukuri N, Brophy J. Dendukuri N, et al. Am J Gastroenterol. 2007 Jan;102(1):201; author reply 202-4. Am J Gastroenterol. 2007. PMID: 17278265 No abstract available.
Similar articles
- Meta-analysis of probiotics for the prevention of traveler's diarrhea.
McFarland LV. McFarland LV. Travel Med Infect Dis. 2007 Mar;5(2):97-105. doi: 10.1016/j.tmaid.2005.10.003. Epub 2005 Dec 5. Travel Med Infect Dis. 2007. PMID: 17298915 - Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii.
Segarra-Newnham M. Segarra-Newnham M. Ann Pharmacother. 2007 Jul;41(7):1212-21. doi: 10.1345/aph.1K110. Epub 2007 Jun 26. Ann Pharmacother. 2007. PMID: 17595306 Review. - Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis.
Kale-Pradhan PB, Jassal HK, Wilhelm SM. Kale-Pradhan PB, et al. Pharmacotherapy. 2010 Feb;30(2):119-26. doi: 10.1592/phco.30.2.119. Pharmacotherapy. 2010. PMID: 20099986 - Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections.
McFarland LV. McFarland LV. Anaerobe. 2009 Dec;15(6):274-80. doi: 10.1016/j.anaerobe.2009.09.002. Epub 2009 Oct 13. Anaerobe. 2009. PMID: 19825425 Review.
Cited by
- Cervical cancer screening utilization and associated factors among women living with HIV in Ethiopia, 2024: systematic review and meta-analysis.
Yirsaw AN, Nigusie A, Andualem F, Getachew E, Getachew D, Tareke AA, Mihret MS, Lakew G. Yirsaw AN, et al. BMC Womens Health. 2024 Sep 19;24(1):521. doi: 10.1186/s12905-024-03362-y. BMC Womens Health. 2024. PMID: 39300442 - Effect of Saccharomyces boulardii on Liver Diseases: A Systematic Review.
Maslennikov R, Benuni N, Levshina A, Adzhieva F, Demina T, Kucher A, Pervushova E, Yuryeva E, Poluektova E, Zolnikova O, Kozlov E, Sigidaev A, Ivashkin V. Maslennikov R, et al. Microorganisms. 2024 Aug 15;12(8):1678. doi: 10.3390/microorganisms12081678. Microorganisms. 2024. PMID: 39203520 Free PMC article. Review. - Turnover intention and its associated factors among nurses in Ethiopia: a systematic review and meta-analysis.
Elfios E, Asale I, Merkine M, Geta T, Ashager K, Nigussie G, Agena A, Atinafu B, Israel E, Tesfaye T. Elfios E, et al. BMC Health Serv Res. 2024 May 24;24(1):662. doi: 10.1186/s12913-024-11122-9. BMC Health Serv Res. 2024. PMID: 38790052 Free PMC article. - The Gut Connection: Exploring the Possibility of Implementing Gut Microbial Metabolites in Lymphoma Treatment.
Al-Khazaleh AK, Chang D, Münch GW, Bhuyan DJ. Al-Khazaleh AK, et al. Cancers (Basel). 2024 Apr 11;16(8):1464. doi: 10.3390/cancers16081464. Cancers (Basel). 2024. PMID: 38672546 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous